The Problem Despite advances in digitizing supply chain management and making data-driven decisions, business planners and executives still expend significant time and effort on understanding ...

The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. Allowing people into your home or property when you’re ...

Available from Jan 13 to Feb 18, 2025, while stocks last. With any purchase of dine-in or takeaway Cereal Chicken Box or Cereal Chicken Burger Box, you can also get a four-inch plushie keychain for ...

Gyeong Hong Jong, a North Korean special forces operative who was killed by Ukraine’s Special Operations Forces (SOF) operatives in Kursk Oblast, has left behind a diary that is now being gradually ...

The FDA's conditional approval for Lumakras (sotorasib; formerly AMG-510) as a second-line treatment for KRAS G12c-mutated non-small cell lung cancer (NSCLC) has come more than two months ahead of ...

Web3 is drowning in metrics, most of which paint an unclear picture. Transaction volumes, token prices and flashy headlines often mask what really matters: the quality of user engagement and the ...

Shibarium integrates Chainlink’s CCIP and CCT standards, enabling SHIB, LEASH, and BONE to operate across 12 blockchains. Chainlink’s Data Streams bring high-frequency market data to Shibarium, ...

Explore key Bitcoin metrics like the Puell Multiple and MVRV Z-Score to understand this cycle’s progress, anticipate price peaks, and prepare for Bitcoin’s potential path toward $200K. With Bitcoin ...

Shiba Inu (SHIB) could be on the cusp of a major lift-off following a groundbreaking partnership with Chainlink (LINK), a leader in blockchain interoperability. Announced on Thursday, this ...

“Recently, we added defactinib to the combination of avutometinib and sotorasib in our RAMP 203 trial. Preliminary data for the triplet combination have shown a generally favorable tolerability ...

Verastem (VSTM) announced preliminary clinical data for the triplet combination of avutometinib and sotorasib plus defactinib in the RAMP 203 Phase 1/2 study in KRAS G12C mutant advanced non-small ...